Regeneron Pharmaceuticals, Inc. is a biotechnology company focused on the discovery, development, manufacturing, and commercialization of innovative medicines that address serious medical conditions. ... Regeneron Pharmaceuticals, Inc. is a biotechnology company focused on the discovery, development, manufacturing, and commercialization of innovative medicines that address serious medical conditions. The company is recognized for its robust research platforms, particularly in the fields of immunology, oncology, and rare diseases. By leveraging advanced genetic and molecular technologies, Regeneron develops therapies targeting a broad spectrum of diseases worldwide, including ophthalmic, cardiovascular, and infectious conditions. Its portfolio includes several blockbuster biologic drugs, further underscoring its scientific leadership in monoclonal antibodies and gene therapy. Regeneron plays a pivotal role in the global healthcare sector, providing treatments that improve patient outcomes and collaborating with external partners to advance new therapeutic options. The company’s strong financial performance, with substantial revenues and consistent profitability, highlights its significant presence and influence within the biotech industry, driving both medical innovation and market growth.Show lessShow more

Disclosures ESG Data Financial Data

GHG Emissions Climate Targets EU Taxonomy Energy Waste Management

Data not available

Regeneron Pharmaceuticals is not subject to EU Taxonomy reporting

Based on current regulatory requirements, Regeneron Pharmaceuticals is not required to report EU Taxonomy data under the CSRD framework. As a result, we have not conducted a detailed EU Taxonomy data review for this company.

If you believe this assessment should be revisited, you may submit a data coverage request and our team will review the company's regulatory applicability.

Would you like us to review Regeneron Pharmaceuticals's data?

Create a free Tracenable account to signal interest in having our team review data for Regeneron Pharmaceuticals.

Legal Center Contact Us